53 captures
28 Mar 2024 - 29 Jul 2026
Mar
APR
May
29
2024
2025
2026
success
fail
About this capture
TIMESTAMPS
The Wayback Machine - https://web-wp.archive.org/web/20250429032205/https://www.nejm.org/toc/nejm/recently-published
Skip to main content
The New England Journal of Medicine
NEJM
NEJM
Evidence
NEJM
AI
NEJM
Catalyst
NEJM
Journal Watch
Sign In
|
Create Account
Subscribe
current issue
VIEW CURRENT ISSUE
BROWSE RECENTLY PUBLISHED
BROWSE ALL ISSUES
SPECIALTIES
Cardiology
Clinical Medicine
Endocrinology
Gastroenterology
Hematology/Oncology
Infectious Disease
Nephrology
Neurology/Neurosurgery
Obstetrics/Gynecology
Pediatrics
Pulmonary/Critical Care
Surgery
View All Specialties
TOPICS
AI in Medicine
Climate Crisis and Health
Coronavirus
Efforts toward Equity
Firearm Injury Prevention
From the National Academy of Medicine
Fundamentals of Medical Ethics
Gray Matters
Health Policy
Medicine and Society
Nutrition in Medicine
Outbreaks Center
Race and Medicine
Recognizing Historical Injustices and the Journal
View All Topics
MULTIMEDIA
Podcasts
Double Takes
Illustrated Glossary
Image Challenge
Images in Clinical Medicine
Interactive Medical Cases
Plain Language/Research Summaries
Quick Takes
Videos in Clinical Medicine
View All Multimedia
LEARNING/CME
Weekly CME
Obesity CME/CE
VIEW ALL LEARNING/CME
AUTHOR CENTER
Advanced Search
SEARCH
Recently Published
Save
Original Article
Apr 28, 2025
Zongertinib in Previously Treated
HER2
-Mutant Non–Small-Cell Lung Cancer
J.V. Heymach and Others
DOI:10.1056/NEJMoa2503704
Original Article
Apr 27, 2025
Nonoperative Management of Mismatch Repair–Deficient Tumors
A. Cercek and Others
DOI:10.1056/NEJMoa2404512
Images in Clinical Medicine
Apr 26, 2025
Cholelithiasis, Cholecystitis, and Choledocholithiasis
Z.-L. Tu and J.-F. Tu
DOI:10.1056/NEJMicm2412996
Perspective
Apr 26, 2025
Routine Surveillance for Cancer Metastases — Does It Help or Harm Patients?
H.G. Welch and L.A. Dossett
DOI:10.1056/NEJMp2414159
Perspective
Apr 26, 2025
A Good Innings — A Tale of Hope, Heartbreak, and Healing
N.D. Sreenath
DOI:10.1056/NEJMp2415146
Perspective
Apr 26, 2025
Death and Taxes — Is Alcohol the Solution?
A.R. Williams
DOI:10.1056/NEJMp2500793
Editorial
Apr 23, 2025
FREE
NEJM Outbreaks Updates — H5N1 in Indiana
E.J. Rubin and Others
DOI:10.1056/NEJMe2503583
Original Article
Apr 23, 2025
Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension
L.J. Laffin and Others
DOI:10.1056/NEJMoa2501440
Sounding Board
Apr 22, 2025
From the National Academy of Medicine
: Climate Change and Human Health — A Research Agenda for Action
V.J. Dzau and Others
DOI:10.1056/NEJMsb2504599
Perspective
Apr 16, 2025
FREE
“Putting America First” — Undermining Health for Populations at Home and Abroad
C.P. Duggan and Z.A. Bhutta
DOI:10.1056/NEJMp2503243
Sounding Board
Apr 10, 2025
From the National Academy of Medicine
: Generative AI in Medicine — Evaluating Progress and Challenges
T.M. Maddox and Others
DOI:10.1056/NEJMsb2503956
Original Article
Apr 08, 2025
Tolebrutinib versus Teriflunomide in Relapsing Multiple Sclerosis
J. Oh and Others
DOI:10.1056/NEJMoa2415985
Original Article
Apr 08, 2025
Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
R.J. Fox and Others
DOI:10.1056/NEJMoa2415988
Original Article
Apr 08, 2025
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis
R.J. Nowak and Others
DOI:10.1056/NEJMoa2501561
Original Article
Apr 02, 2025
A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis
D. Blockmans and Others
DOI:10.1056/NEJMoa2413449
Original Article
Mar 31, 2025
Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death
M. Humbert and Others
DOI:10.1056/NEJMoa2415160
Original Article
Mar 30, 2025
Routine Cerebral Embolic Protection during Transcatheter Aortic-Valve Implantation
R.K. Kharbanda and Others
DOI:10.1056/NEJMoa2415120
Original Article
Mar 30, 2025
Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a)
S.E. Nissen and Others
DOI:10.1056/NEJMoa2415818
Original Article
Mar 30, 2025
Global Effect of Cardiovascular Risk Factors on Lifetime Estimates
The Global Cardiovascular Risk Consortium
DOI:10.1056/NEJMoa2415879
Original Article
Mar 29, 2025
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
D.K. McGuire and Others
DOI:10.1056/NEJMoa2501006
Perspective
Mar 26, 2025
Disappearing Data at the U.S. Federal Government
J. Freilich , W.N. Price II , and A.S. Kesselheim
DOI:10.1056/NEJMp2502567
Original Article
Mar 19, 2025
A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes
Y.C. Kudva and Others
DOI:10.1056/NEJMoa2415948
Perspective
Feb 26, 2025
Medicaid on the Chopping Block
E. Park
DOI:10.1056/NEJMp2501855
Perspective
Feb 12, 2025
The Consequences of Silencing the “Voice of CDC”
S.A. Rasmussen and Others
DOI:10.1056/NEJMp2501622
Original Article
Feb 07, 2025
Brief Report: Xenotransplantation of a Porcine Kidney for End-Stage Kidney Disease
T. Kawai and Others
DOI:10.1056/NEJMoa2412747
Original Article
Dec 09, 2024
Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma
M.A. Dimopoulos and Others
DOI:10.1056/NEJMoa2409029
